Legislative Activity
Track Tom's sponsored bills, co-sponsored legislation, and voting record
This bill mandates the President to designate Ansarallah as a foreign terrorist organization and determine if specific individuals are affiliated, triggering sanctions for international terrorism.
Ted Cruz
Senator
TX
Ted Cruz
Senator
TX
This bill mandates the President to designate Ansarallah as a foreign terrorist organization. Within 30 days of this designation, the President must report to Congress whether certain individuals are officials, agents, or affiliates of Ansarallah.
This bill allows individuals with a valid concealed carry permit or the legal right to carry a concealed firearm in their home state to do so in any other state that allows concealed carry, subject to the same restrictions as residents of that state. It does not override state laws regarding the issuance of concealed carry permits.
John Cornyn
Senator
TX
John Cornyn
Senator
TX
The "Constitutional Concealed Carry Reciprocity Act of 2025" permits individuals legally authorized to carry a concealed firearm in their home state to do so in any other state that allows concealed carry, provided they possess a valid photo ID and either a concealed carry permit or the legal right to carry without one in their home state. When carrying a concealed handgun in another state, individuals must adhere to the same restrictions imposed on residents of that state. This law does not override state laws regarding the issuance of concealed carry licenses or permits.
The "Skinny Labels, Big Savings Act" amends patent law to clarify that seeking FDA approval for generic drugs, animal drugs, or biosimilars, and marketing them with FDA-approved labeling that omits patented uses, does not constitute patent infringement, encouraging generic competition and cost savings.
John Hickenlooper
Senator
CO
John Hickenlooper
Senator
CO
The "Skinny Labels, Big Savings Act" aims to reduce drug costs by clarifying that generic drug manufacturers are not infringing on patents when seeking FDA approval for a use of a drug that is no longer covered by patent ("skinny label"). The bill amends patent law to create a safe harbor for generic drug manufacturers who seek FDA approval for a drug with a label that excludes any uses still covered by patents. This exemption extends to the promotion and marketing of the drug, as long as it does not reference the patented condition of use. The bill also includes similar provisions for biosimilar biological products.
The CBW Fentanyl Act amends existing legislation to impose sanctions on foreign individuals and countries involved in chemical or biological weapons programs, particularly those related to fentanyl production, and requires presidential reports to Congress on these activities. It also outlines a tiered system of sanctions that can be imposed and subsequently terminated based on a country's compliance and actions to prevent future violations.
Jim Banks
Senator
IN
Jim Banks
Senator
IN
The CBW Fentanyl Act amends the Chemical and Biological Weapons Control and Warfare Elimination Act of 1991 to expand sanctions for countries and individuals involved in chemical or biological weapons programs, including those related to fentanyl production. It mandates presidential reports to Congress on foreign individuals or entities involved in "covered acts" related to such programs, triggering a tiered system of sanctions based on the country's response. These sanctions range from suspending scientific cooperation to prohibiting transactions within U.S. jurisdiction, with potential waivers for national security interests and a sunset clause after five years. The bill aims to counter the weaponization of fentanyl by targeting international actors contributing to its production and distribution.